# Harbright 2026 VQ Biomedical Series, a series of Harbright LLC — Form D

Harbright 2026 VQ Biomedical Series, a series of Harbright LLC of CARY, NC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-07-08. The offering totals $1.0M, of which $597K was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2026-07-08
- Form: D
- Accession: 0002138549-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.1
- Total offering: $1.0M
- Amount sold: $597K
- Remaining: $403K
- Minimum investment: $10K
- Investors: 15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-590029

## Issuer

- Name: Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
- CIK: 0002138549
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 107 KILMAYNE DRIVE SUITE B, CARY, NC, 27511
- Phone: 9193356001

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| John Michael Harlow | Related Person | Clayton, NC |
| John Powell Leachman | Related Person | Gainesville, GA |
| Robert Earl Ross | Related Person | Cary, NC |

## More

- [CIK 2138549 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2138549&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002138549-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.